Sixfold Bioscience
PrivateLast Round
Grant
Aug 22, 2023
Total Funding Raised
$13.24M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sixfold Bioscience operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Grant round in August 2023.
Sixfold Bioscience is a biotechnology company that develops programmable drug delivery systems for RNA therapeutics using computation and advanced chemistry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sixfold Bioscience Comparables
Compare Sixfold Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nuntius Therapeutics | 88% | |
| Sapreme Technologies BV | 87% | |
| Undecimal Bio | 86% |
For institutional investors. Book with your work email.
Sixfold Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 22, 2023 | ||||
| Grant | Mar 1, 2023 | ||||
| Seed | Dec 2, 2021 | ||||
| Grant | Sep 23, 2020 | ||||
| Grant | Aug 4, 2020 | ||||
Grant | Sep 17, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sixfold Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Pi Campus | Seed |
| European Commission | Seed |
| Cantos Ventures | Seed |
| Innovate UK | Seed, Grant |
| Y Combinator | Seed, Accelerator |
| Lombardstreet Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 159% MoM, reaching 2.1K.
- Aug 22, 2023
$960K grant received from Innovate UK.
For institutional investors. Book with your work email.
Sixfold Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sixfold Bioscience's valuation, stock price, and market status.
Is Sixfold Bioscience a public or private company?
Sixfold Bioscience is a private company.
What is the current stock price of Sixfold Bioscience?
Sixfold Bioscience is a private company, so its shares have no public market price. Caplight tracks Sixfold Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sixfold Bioscience worth (valuation)?
Valuation information for Sixfold Bioscience is not publicly available.
Can I buy Sixfold Bioscience stock?
Sixfold Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sixfold Bioscience's last funding round?
Sixfold Bioscience's most recent funding round was Grant on August 22, 2023.
Who are the main investors in Sixfold Bioscience?
Key investors in Sixfold Bioscience include Y Combinator.
Will Sixfold Bioscience IPO soon?
No public IPO plans have been announced for Sixfold Bioscience.
How can I track Sixfold Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Sixfold Bioscience's shares on secondary markets.